Use of Postbiotics as an Immunomodulatory of the Immune Response against Brucellosis in Nellore Calves Immunized with S 19 Vaccine

Background: Brucellosis is an important public health disease and a great problem in the cattle production. Objectives: The aim of this study was to evaluate the immunomodulatory efficiency of a commercial postbiotic in Nellore calves immunized with the Brucella abortus S19 vaccine. Methods: We used 40 calves negative for Brucella spp. organizated into four treatments during 15 days: InRum (Ingulbal Ruminant®); InPro (Ingulbal Protein®); RumPro (Ingulbal Ruminant® and Ingulbal Protein®); and Cont: control. Collections of whole blood and serum samples were performed at the beginning of the administration of postbiotic and at 15, 45, 75 and 105 days after start the experiment. At 15 days, all animals received the mandatory vaccine S19. In order to assess immunological parameters, the means of total white cells counts, total lymphocytes, monocytes and neutrophils, and total IgG antibodies were determined. Results: It found a significative increase (P<0.05) of white cells counts and serum IgG levels in the three treatment groups throughout the experiment. Additionally, we observe a tendency not significative in a greater number of lymphocytes, monocytes and neutrophils counts in the treat calves. Conclusion: Our results suggest that the supplementation with postbiotic is a promising alternative to modulate both the cellular and humoral immune response of S19 vaccine against bovine brucellosis.

Download Full-text

Dynamic landscape mapping of humoral immunity to SARS-CoV-2 identifies non-structural protein antibodies associated with the survival of critical COVID-19 patients

Signal Transduction and Targeted Therapy ◽

10.1038/s41392-021-00718-w ◽

2021 ◽

Vol 6 (1) ◽

Cited By ~ 1

Author(s):

Linlin Cheng ◽

Xiaomei Zhang ◽

Yu Chen ◽

Dan Wang ◽

Dong Zhang ◽

...

Keyword(s):

Immune Response ◽

Humoral Immunity ◽

High Mortality ◽

Good Prognosis ◽

Igg Antibodies ◽

Structural Protein ◽

Nonstructural Proteins ◽

Serum Samples ◽

Humoral Immune ◽

Global Correlation

AbstractA comprehensive analysis of the humoral immune response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential in understanding COVID-19 pathogenesis and developing antibody-based diagnostics and therapy. In this work, we performed a longitudinal analysis of antibody responses to SARS-CoV-2 proteins in 104 serum samples from 49 critical COVID-19 patients using a peptide-based SARS-CoV-2 proteome microarray. Our data show that the binding epitopes of IgM and IgG antibodies differ across SARS-CoV-2 proteins and even within the same protein. Moreover, most IgM and IgG epitopes are located within nonstructural proteins (nsps), which are critical in inactivating the host’s innate immune response and enabling SARS-CoV-2 replication, transcription, and polyprotein processing. IgM antibodies are associated with a good prognosis and target nsp3 and nsp5 proteases, whereas IgG antibodies are associated with high mortality and target structural proteins (Nucleocapsid, Spike, ORF3a). The epitopes targeted by antibodies in patients with a high mortality rate were further validated using an independent serum cohort (n = 56) and using global correlation mapping analysis with the clinical variables that are associated with COVID-19 severity. Our data provide fundamental insight into humoral immunity during SARS-CoV-2 infection. SARS-CoV-2 immunogenic epitopes identified in this work could also help direct antibody-based COVID-19 treatment and triage patients.

Download Full-text

Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)

Infectious Agents and Cancer ◽

10.1186/s13027-021-00375-2 ◽

2021 ◽

Vol 16 (1) ◽

Author(s):

Ernesta Cavalcanti ◽

Maria Antonietta Isgrò ◽

Domenica Rea ◽

Lucia Di Capua ◽

Giusy Trillò ◽

...

Keyword(s):

Immune Response ◽

Immune Responses ◽

Healthcare Workers ◽

Geometric Mean ◽

Vaccination Strategy ◽

Antibody Responses ◽

Cancer Center ◽

Serum Samples ◽

Humoral Immune ◽

History Of

Abstract Background Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and the resulting disease, coronavirus disease 2019 (COVID-19), have spread to millions of people globally, requiring the development of billions of different vaccine doses. The SARS-CoV-2 spike mRNA vaccine (named BNT162b2/Pfizer), authorized by the FDA, has shown high efficacy in preventing SARS-CoV-2 infection after administration of two doses in individuals 16 years of age and older. In the present study, we retrospectively evaluated the differences in the SARS-CoV-2 humoral immune response after vaccine administration in the two different cohorts of workers at the INT - IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy): previously infected to SARS-CoV-2 subjects and not infected to SARS-CoV-2 subjects. Methods We determined specific anti-RBD (receptor-binding domain) titers against trimeric spike glycoprotein (S) of SARS-CoV-2 by Roche Elecsys Anti-SARS-CoV-2 S immunoassay in serum samples of 35 healthcare workers with a previous documented history of SARS-CoV-2 infection and 158 healthcare workers without, after 1 and 2 doses of vaccine, respectively. Moreover, geometric mean titers and relative fold changes (FC) were calculated. Results Both previously infected and not infected to SARS-CoV-2 subjects developed significant immune responses to SARS-CoV-2 after the administration of 1 and 2 doses of vaccine, respectively. Anti-S antibody responses to the first dose of vaccine were significantly higher in previously SARS-CoV-2-infected subjects in comparison to titers of not infected subjects after the first as well as the second dose of vaccine. Fold changes for subjects previously infected to SARS-CoV-2 was very modest, given the high basal antibody titer, as well as the upper limit of 2500.0 BAU/mL imposed by the Roche methods. Conversely, for naïve subjects, mean fold change following the first dose was low ($$ \overline{x} $$ x ¯ =1.6), reaching 3.8 FC in 72 subjects (45.6%) following the second dose. Conclusions The results showed that, as early as the first dose, SARS-CoV-2-infected individuals developed a remarkable and statistically significant immune response in comparison to those who did not contract the virus previously, suggesting the possibility of administering only one dose in previously SARS-CoV-2-infected subjects. FC for previously infected subjects should not be taken into account for the generally high pre-vaccination values. Conversely, FC for not infected subjects, after the second dose, were = 3.8 in > 45.0% of vaccinees, and ≤ 3.1 in 19.0%, the latter showing a potential susceptibility to further SARS-CoV-2 infection.

Download Full-text

Some immunological studies on a new vaccine derived frombacteriophage lysate of Pasteurella multocida in mice

Indian Journal of Animal Research ◽

10.18805/ijar.v0iof.7000 ◽

2017 ◽

Author(s):

Hari Mohan Saxena ◽

Yanglem Pushpa ◽

Sabia Qureshi

Keyword(s):

Immune Response ◽

Serum Protein ◽

Humoral Immune Response ◽

Protein Concentration ◽

Pasteurella Multocida ◽

Phage Lysate ◽

Serum Globulin ◽

Humoral Immune ◽

Serum Igg Levels ◽

Serum Protein Concentration

The study was undertaken to evaluate the humoral immune response in mice induced by a novel phage lysate vaccine against Hemorrhagic Septicemia developed from Pasteurella multocida grown under iron-restricted conditions and lysed by a bacteriophage. Two groups of mice were immunized with lysate vaccine (LV) and conventional killed HS vaccine (CV) and blood was collected at various days post – immunization (DPI). The serum protein concentration in lysate vaccinated mice (4.675±0.223) was significantly higher (p less than 0.05) than the conventional vaccinated mice (4.100±0.282) at 150 DPI. The serum globulin levels at 90 DPI and 180 DPI in LV mice (1.330±0.071 and 0.650±0.100) were significantly (p less than 0.01) higher than the CV mice (0.850±0.084 and 0.366±0.098). The serum IgG levels at 150 DPI and 180 DPI in LV (0.564±0.188 and 0.485±0121) mice were significantly higher (p less than 0.01) than the CV mice (0.178±0.039 and 0.121±0.026). Although our results in mice are promising, further studies involving bovines are needed.

Download Full-text

The Humoral Immune Response to Various Domains of Protective Antigen of Bacillus anthracis in Cutaneous Anthrax Cases in India

Defence Science Journal ◽

10.14429/dsj.66.10805 ◽

2016 ◽

Vol 66 (6) ◽

pp. 645 ◽

Cited By ~ 3

Author(s):

Anshul Varshney ◽

Nidhi Puranik ◽

M. Kumar ◽

A.K. Goel

Keyword(s):

Immune Response ◽

Bacillus Anthracis ◽

Humoral Immune Response ◽

Vaccine Development ◽

Protective Antigen ◽

Lethal Factor ◽

Serum Samples ◽

Public Health Importance ◽

Humoral Immune ◽

Cutaneous Anthrax

Anthrax, caused by Bacillus anthracis is known to occur globally since antiquity. Besides being an important biothreat agent, it is an important public health importance pathogen also in countries like India. B. anthracis secretes three distinct toxins, namely protective antigen (PA), lethal factor (LF) and edema factor (EF). PA is the central moiety of the anthrax toxin complex and therefore has been a molecule of choice for vaccine development. PA has four different domains with different functions. In this study, the major domains of PA were cloned and expressed in bacterial system. The purified recombinant proteins were used to determine the humoral immune response by ELISA using 43 human cutaneous anthrax serum samples. The maximum immunoreactivity was observed with the whole PA protein followed by domain 2, 4 and 1. The study corroborated that in addition to full PA, individual domain 2 and 4 can also be good target for vaccine development as well as for serodiagnostic assays for cutaneous anthrax

Download Full-text

Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder

Multiple Sclerosis Journal - Experimental Translational and Clinical ◽

10.1177/2055217317742425 ◽

2017 ◽

Vol 3 (4) ◽

pp. 205521731774242 ◽

Cited By ~ 1

Author(s):

Giannina Arru ◽

Elia Sechi ◽

Sara Mariotto ◽

Alessia Farinazzo ◽

Chiara Mancinelli ◽

...

Keyword(s):

Multiple Sclerosis ◽

Immune Response ◽

Neuromyelitis Optica ◽

Humoral Immune Response ◽

Serum Levels ◽

Spectrum Disorder ◽

Antigenic Peptides ◽

Neuromyelitis Optica Spectrum Disorder ◽

Serum Samples ◽

Humoral Immune

Background A specific humoral immune response against HERV-W envelope surface (env-su) glycoprotein antigens has been reported in serum of patients with multiple sclerosis (MS). However, it has not been evaluated to date in patients with neuromyelitis optica spectrum disorder (NMOSD). Objective The objective of this paper is to investigate whether antibody (Ab) response against HERV-W env-su antigenic peptides differs between NMOSD and MS. Methods Serum samples were collected from 36 patients with NMOSD, 36 patients with MS and 36 healthy control individuals (HCs). An indirect ELISA was set up to detect specific Abs against HERV-W env-su peptides. Results Our data showed that two antigenic peptides, particularly HERV-Wenv93–108 and HERV-Wenv248–262, were statistically significantly present only in serum of MS compared to NMOSD and HCs. Thus, the specific humoral immune response against HERV-W env-su glycoprotein antigens found in MS is widely missing in NMOSD. Conclusion Increased circulating serum levels of these HERV-W Abs may be suitable as additional biomarkers to better differentiate MS from NMOSD.

Download Full-text

Pathological changes inducing by S.aureus in immunodeficiency mice immunized with Soluble Culture Filtrate S.aureus Antigens (SCFAgs)

Al-Qadisiyah Journal of Veterinary Medicine Sciences ◽

10.29079/vol12iss1art233 ◽

2013 ◽

Vol 12 (1) ◽

pp. 71

Author(s):

H. H. K. AL-Byattee

Keyword(s):

Immune Response ◽

Immune Responses ◽

Culture Filtrate ◽

Post Inoculation ◽

Bacterial Isolation ◽

Positive Group ◽

Treatment Groups ◽

Humoral Immune ◽

Sterile Normal Saline ◽

Cellular Immune

In order to determine the influence of Soluble Culture Filtrate S.aureus Antigens (SCFAgs)on S.aureus infection in Mitomicin c immunosupression mice, seventy four white mice, both sex,7-8 weeks age were divided randomly into five groups.1st group(n=16 ) was immunized with 0.4ml of S.aureus CFSAgs (concentration of protein( 4.2mg/ml) ,i/p two doses, 2 weeks intervals. 2nd group(n=16) was injected with mitomycine C ,(1mg/kg B.W) I/p three time /week for 4 weeks. 3ed group (n=16) was immunized with CFSAgs as 1st group and treated with mitomycin as 2nd group. 4th group(n=10) was inoculated with (0.4ml) I/P with1X109 CFU/ML of viable virulent. S.aureus and was served as control positive group. 5th group (n=16) was inoculated with 0.5ml sterile normal saline. Cellular and humoral immune response were recorded at 28-30 day post immunization, skin test and passive heam agglutination test respectively, then all animals of immunized and treatment groups were challenge with S,aureus as control positive group. The results explained that animals treatment with MMC were died during (18) hrs post inoculation with virulent viable S.aureus with very heavy bacterial isolation, animal of control positive group were died at( 24)hrs post infection with heavy bacterial isolation The results revealed that immunization with CFSAgs elicited both humoral and cellular immune responses, the level values of both arms of immune response were lower animal treatment with MMC, Severe pathological lesions were seen in examined organs of control positive group but these lesions are more extensive in animal treatment with MMC. The main lesions in examined organs of these animals are suppurative inflammation ,congestion ,apoptosis and necrosis.. We conclusion that MMC induce immunosuppression condition and immunization with CFSAgs can improve the immune responses in the animals that are suffering from immunosuppression.

Download Full-text

Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection in the population of an oncology hospital in Poland. Criteria for COVID-19 re-immunization are needed.

10.21203/rs.3.rs-858160/v4 ◽

2021 ◽

Author(s):

Piotr Kosiorek ◽

Dorota Kazberuk ◽

Anna Hryniewicz ◽

Robert Milewski ◽

Samuel Stróż ◽

...

Keyword(s):

Immune Response ◽

Humoral Immune Response ◽

Post Infection ◽

Half Life ◽

Humoral Response ◽

Control Group ◽

Igg Antibodies ◽

Hospital Laboratory ◽

Humoral Immune ◽

Chemiluminescent Immunoassay

Abstract Systemic vaccination of the BNT162b2 mRNA stimulates humoral response. Our study aimed to compare the intensity of humoral immune response, measured by SARS CoV-2 IgG, SARS CoV-2 IgM, and neutralization S-RBD IgG antibodies level, post COVID-19 vaccination versus post-SARS COV-2 infection. We analysed 1060 people in the following groups: convalescents, healthy vaccinated, vaccinated with COMIRNATY, AstraZeneca, Moderna, Johnson & Johnson, and vaccinated SARS CoV-2 convalescents. A concentration of SARS CoV-2 IgG, SARS CoV-2 IgM, and neutralizing S-RBD IgG was estimated in hospital laboratory by chemiluminescent immunoassay - CLIA, MAGLUMI. Results: 1. We observed a rise of antibodies response in both convalescent SARS CoV-2 and COVID-19 vaccinated groups 2. The level of all antibodies’ concentrations in vaccinated COVID-19 convalescents was significantly higher. 3. We differentiated asymptomatic SARS CoV-2 convalescents from the control group. Based on our analysis, we suggest that it is essential to monitor SARS CoV-2 antibodies concentrations as an indicator of asymptomatic COVID-19 infection and equivalent to the effectiveness of humoral response in convalescents and vaccinated people. Considering the time-limited nature of the effects of post-infection SARS CoV-2 recovery or vaccination, among others physiological half-life, we suggested monitoring IgG antibodies level as a criterium for the next vaccination.

Download Full-text

THE IMPORTANCE OF BRUCELLIN ALGERIC SKIN TEST FOR DIAGNOSIS OF BOVINE BRUCELLOSIS

ВЕТЕРИНАРСКИ ЖУРНАЛ РЕПУБЛИКЕ СРПСКЕ ◽

10.7251/vetjen1802392v ◽

2019 ◽

Vol 18 (2) ◽

Author(s):

Lejla Velić ◽

Toni Eterović ◽

Silvio Špičić ◽

Željko Cvetnić ◽

Amina Hrković Porobija ◽

...

Keyword(s):

Immune Response ◽

Immune Responses ◽

Skin Test ◽

Yersinia Enterocolitica ◽

High Specificity ◽

Cross Reactivity ◽

Bovine Brucellosis ◽

Specific Antibodies ◽

Humoral Immune ◽

Allergic Skin

Infection with Brucella results in the induction of both humoral andcellular immune responses. Humoral immune resposne is based on monitoringthe occurrence of specific antibodies against smooth lipopolysaccharide (S-LPS)of Brucella. However, in cattle, classical serological methods can detect antigenicdeterminants for other types of microorganisms (cross reactivity) such as Escherichiacoli 0:157, Yersinia enterocolitica 0:9, Salmonella urban, Pseudomonas malthopilia andPasteurella. The aim of our work was to determine the immunological responsebased on the use of standardized and purified allergen in which lypopolysaharid hasbeen removed and doesn’t induce humoral immune response. A total of 16 dairycattle previously tested positive using RBT (Rose Bengal test) and CFT (complementfixation test) were tested for confirmation with BST (brucelline skin test) accordingto the instructions of the producer. B. melitensis B115 (Synbiotics BrucellergeneOCB) was used in the test. 14 of 16 cattle reacted with skin thickening >1 mm after72 hours from the application of brucellin. 2 animals with no skin thickening orthickening <1mm also reacted negative in CFT. This outcome can be attributed tocross reactions with other antigens than Brucella that commonly occurs in RoseBengal test.Brucellin allergic skin test is not recommended as a standalone diagnostic toolbecause all infected animals do not react therefore this test cannot be recommendedas a self-sufficient diagnostic test or for the purpose of international trade.However, due to high specificity and adequate sensitivity at the herd level, it can berecommended for the control of herds in areas free of brucellosis.

Download Full-text

Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients

Journal of Clinical Medicine ◽

10.3390/jcm10215153 ◽

2021 ◽

Vol 10 (21) ◽

pp. 5153

Author(s):

Seyedesomaye Jasemi ◽

Gian Luca Erre ◽

Maria Luisa Cadoni ◽

Marco Bo ◽

Leonardo A. Sechi

Keyword(s):

Rheumatoid Arthritis ◽

Immune Response ◽

Humoral Immune Response ◽

Humoral Response ◽

Human Endogenous Retrovirus ◽

Serum Samples ◽

Humoral Immune ◽

Bivariate Correlation ◽

Microbial Biomarkers ◽

Significant Difference

Background/Objective: Chronic humoral immune response against multiple microbial antigens may play a crucial role in the etiopathogenesis of rheumatoid arthritis (RA). We aimed to assess the prevalence and magnitude of antibody response against various bacterial and viral immunogen peptides in the sera of RA patients compared with the general population. Methods: Polyclonal IgG antibodies (Abs) specific for peptides derived from Porphyromonas gingivalis (RgpA, Kpg), Aggregatibacter actinomycetemcomitans (LtxA1, LtxA2), Mycobacterium avium subsp. paratuberculosis (MAP4027), Epstein–Barr virus (EBNA1, EBVBOLF), and human endogenous retrovirus (HERV-W env-su) were detected by ELISA in serum samples from 148 consecutive RA patients and 148 sex and age-matched healthy controls (HCs). In addition, the presence of a relationship between the positivity and the titer of antibodies and RA descriptors was explored by bivariate correlation analysis. Results: RA patients exhibit a higher prevalence of humoral immune response against all tested peptides compared to HCs with a statically significant difference for MAP4027 (30.4% vs. 10.1%), BOLF (25.7% vs. 8.1%), RgpA (24.3% vs. 9.4%), HERV W-env (20.3% vs. 9.4%), and EBNA1 (18.9% vs. 9.4%) peptides. Fifty-three (35.8%) out of 148 RA serum and 93 (62.8%) out of 148 HCs were negative for all pathogen-derived peptides. There was a significant correlation between OD values obtained by ELISA test against all peptides (p < 0.0001). We also found an increased titer and prevalence of Abs against LtxA1 and LtxA2 in seropositive vs. seronegative RF (p = 0.019, p = 0.018). Conclusion: This study demonstrates a significantly increased humoral response against multiple pathogens in patients with RA and implies that they could be an important factor in the pathogenesis of the disease. Therefore, the role of each individual pathogen in RA needs to be further investigated.

Download Full-text

Systemic COVID-19 vaccination also enhances the humoral immune response after SARS CoV-2 infection in the population of an oncology hospital in Poland. Criteria for COVID-19 re-immunization are needed.

10.21203/rs.3.rs-858160/v3 ◽

2021 ◽

Author(s):

Piotr Kosiorek ◽

Dorota Kazberuk ◽

Anna Hryniewicz ◽

Robert Milewski ◽

Samuel Stróż ◽

...

Keyword(s):

Immune Response ◽

Humoral Immune Response ◽

Post Infection ◽

Half Life ◽

Humoral Response ◽

Control Group ◽

Igg Antibodies ◽

Humoral Immune ◽

Chemiluminescent Immunoassay ◽

Oncology Center

Abstract Systemic vaccination of the BNT162b2 mRNA stimulates humoral response. The aim of our study was to compare the intensity of humoral immune response, measured by SARS CoV-2 IgG, SARS CoV-2 IgM, and neutralization S-RBD IgG antibodies level, post COVID-19 vaccination versus post SARS COV-2 infection. We analysed 1060 people in the following groups: convalescents, healthy vaccinated, vaccinated with COMIRNATY, AstraZeneca, Moderna, Johnson&Johnson and vaccinated SARS CoV-2 convalescents. A concentration of SARS CoV-2 IgG, SARS CoV-2 IgM, and neutralizing S-RBD IgG was estimated in Bialystok Oncology Center laboratory by chemiluminescent immunoassay- CLIA, MAGLUMI. Results: 1. We observed a raise of antibodies response in both, convalescent SARS CoV-2 and COVID-19 vaccinated groups 2. The level of all antibodies’ concentrations in vaccinated COVID-19 convalescents was significantly higher. 3. We differentiated an asymptomatic SARS CoV-2 convalescents from control group. Based on our analysis we suggest that it is important to monitor SARS CoV-2 antibodies concentrations as an indicator of asymptomatic COVID-19 infection, and as an equivalent of effectiveness of humoral response in convalescents and vaccinated people. Taking into consideration the time-limited nature of the effects of post infection SARS CoV-2 recovery or vaccination, among others physiological half-life, we suggested monitoring IgG antibodies level as a criterium for next vaccination.

Download Full-text